Weigh the evidence
A hormone change is not the whole result.
When a page says “research shows,” ask who was studied and what actually changed. That is where the useful detail begins.
The child-growth trial answers a child-growth question
Growth hormone is a body chemical that helps children grow. Thorner’s 1996 trial enrolled 110 children with a diagnosed shortage of it and measured growth in 86 of them.
The starting growth rate averaged about 4 centimeters per year; during the first study year it reached about 7 to 8 centimeters per year.
The trial had no group for comparison. Its participants were children who lacked enough growth hormone. Adult energy and body shape were outside this trial’s question.
A centimeter is a measure of length; the figures describe a yearly growth rate, not a promised gain for a reader.
The adult studies leave a lot open
Small studies published in 1992 and 1997 involved only 10 to 19 older adults each and lasted 2 to 16 weeks.
Some tested sermorelin. One tested a close copy with one building block changed, so it was a different substance.
Growth hormone rose. IGF-1, a substance linked to growth hormone and measured in blood, rose in some studies but stayed unchanged in another.
Body-fat measurements did not move in the studies that tracked them.
These findings do not establish lasting improvements in adult health.
Ask for a study of the result you care about, in people like you, using the same ingredient and way of taking the medicine.
Sleep claims need the same care
In some sleep-lab studies, researchers put the natural hormone into a vein to prompt growth hormone release. That differs from giving sermorelin under the skin.
A 16-week study in older adults used the close copy with one building block changed, given by injection under the skin. It found no change in sleep quality.
A result from a related substance is not a direct test of the medicine being offered. Ask which study supports that offer.